This paper made a comparison of extracting antigen of S. Mutans by three groups of protein isolation solution under different time and temperature.
本文对三组不同组分的蛋白解离液在不同温度和时间对变链球菌细胞表面蛋白抗原的提取进行了比较。
ObjectiveTo find a rapid and effective method for isolation of retinal s antigen.
目的寻找分离纯化牛视网膜s抗原的快速高效方法。
Results: The new gene encoding the antigen epitope of SARS-CoV S protein was designed and synthesized successfully, and it was highly expressed in E coli.
结果：设计并合成了SARS冠状病毒S蛋白的抗原表位序列的新基因序列，在大肠杆菌中实现了该基因的高表达。
Objective To determine whether the subretinal space supports the induction of deviant immune responses to retinal soluble(S) antigen.
目的确立视网膜下腔是否具有支持针对视网膜可溶性抗原（S抗原）刺激诱导偏离式免疫反应的能力。
Methods: DCs were derived from cord blood monocytes, then were pulsed by tumor associated antigen (TAA) extracted from human stomach cancer S-180 cell line.
方法：采用脐带血来源的单核细胞制备树突状细胞，体外经s - 180细胞肿瘤相关抗原(TAA)致敏后免疫小鼠，一周后接种s - 180细胞株。
ConclusionThe subretinal space supports immune deviation for retinal s antigen by activity suppressing antigen specific DTH.
结论视网膜下腔具有通过抑制抗原特异性D TH支持针对可溶性抗原的免疫偏离的诱导能力。
Objective: to study the effect of injection bovine retinal soluble antigen (S-Ag) into anterior chamber (AC) in inducing immunological tolerance.
目的：探讨眼前房内注射牛视网膜可溶性抗原(S抗原)在诱导眼免疫耐受中的作用。
Methods The number of apoptosis cells were identified by TUNEL method and the expression intensity of antigen CD57 in lymph cells nearby the carcinoma was determined by S-P method.
方法通过TUNEL法检测三类乳腺癌中凋亡细胞数量及分布比例的差异，采用S-P免疫组化法检测癌周淋巴细胞中CD57抗原表达强度的差异。
Methods: By analyzing the antigen epitope of SARS-CoV s protein with antigenic peptides prediction software, a new gene was designed, and its expression vector was constructed.
方法：应用生物信息学分析软件分析SARS冠状病毒S蛋白的抗原表位序列，设计全新的抗原表位编码基因序列，构建表达载体并在大肠杆菌中表达该基因。
METHODS The syngeneic S-100 antigen emulsified in complete Freud's adjuvant was injected intraperitoneally twice, serum alanine aminotransferase level and histological grade were observed dynamically.
方法以同种系s - 100肝抗原与弗氏完全佐剂充分乳化后两次予小鼠腹腔注射，并观察其血清谷丙转氨酶和肝组织学分级的动态变化。
The antigen had been emulsified with Freund' s complete adjuvant in the earlier 3 times and with Freund' s incomplete adjuvant in the latter 3 times.
前3次免疫时采用的是弗氏完全佐剂乳化，后3次免疫采用弗氏不完全佐剂乳化。
The antigen had been emulsified with Freund' s complete adjuvant in the earlier 3 times and with Freund' s incomplete adjuvant in the latter 3 times.
前3次免疫时采用的是弗氏完全佐剂乳化，后3次免疫采用弗氏不完全佐剂乳化。
应用推荐